Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-up of Patients with Mantle Cell Lymphoma Treated with Venetoclax Monotherapy

Matthew S. Davids, MD, Andrew W. Roberts, MBBS, PhD, William G. Wierda, MD PhD, Kathryn Humphrey, Debbie J Alter, RN, BSN, Abdullah Masud, PhD, Eike C. Buss, MD, Maria E. Verdugo, John F. Seymour, MBBS, PhD

Blood (2018) 132 (Supplement 1): 2883.

https://doi.org/10.1182/blood-2018-99-117210

Published: 2018

Journal Articles

In-Depth Quantitative Multiplex Proteomics Reveal Subtype-Specific Differences Among Functionally Validated AML Stem Cell Populations

Simon Raffel, MD, Jenny Hansson, PhD, Carl Herrmann, PhD, Christoph Lutz, MD, Eike C. Buss, MD, Christian Thiede, MD, Anne Floercken, MD, Oliver Bischel, MD, Joerg Westermann, MD, Gerhard Ehninger, MD, Anthony D Ho, MD, Roland Eils, PhD, Jeroen Krijgsveld, PhD, Andreas Trumpp, PhD

Blood (2014) 124 (21): 2144.

https://doi.org/10.1182/blood.V124.21.2144.2144

Published: 2014

Journal Articles

Favorable Outcome in a Large Cohort of Prospectively Treated Adult Patients with T-Lymphoblastic Lymphoma (T-LBL) Despite Slowly Evolving Complete Remission Assessed By Conventional Radiography

Nicola Gökbuget, MD, Andrea Wolf, Matthias Stelljes, MD, Andreas Hüttmann, MD, Eike C. Buss, Andreas Viardot, Kalina Brandt, MD, Maike de Wit, MD, Norbert Frickhofen, MD, Maxim Kebenko, MD, Mustafa Kondakci, MD, Doris Kraemer, MD, Stefan Schwartz, MD, Hubert Serve, MD, Karsten Spiekermann, MD, Reingard Stuhlmann, MD, Albrecht Reichle, Dieter Hoelzer, MD

Blood (2014) 124 (21): 370.

https://doi.org/10.1182/blood.V124.21.370.370

Published: 2014

Journal Articles

BLAST: A Confirmatory, Single-Arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE ® ) Antibody Construct, in Patients with Minimal Residual Disease B-Precursor Acute Lymphoblastic Leukemia (ALL)

Nicola Goekbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Violaine Havelange, Eike C. Buss, Christoph Faul, Monika Bruggemann, Arnold Ganser, Julia Stieglmaier, Hendrik Wessels, Vincent Haddad, Gerhard Zugmaier, Dirk Nagorsen, Ralf C. Bargou

Blood (2014) 124 (21): 379.

https://doi.org/10.1182/blood.V124.21.379.379

Published: 2014

Journal Articles

Expression Of Aldehyde Dehydrogenase Reflected Diverse Stem Cell Properties In Acute Myeloid Leukemia

Van T. Hoang, Eike C. Buss, MD, Isabel Hoffmann, PhD, Abraham Zepeda-Moreno, MD, Natalia Baran, Volker Eckstein, PhD, Anna Jauch, PhD, Anthony D. Ho, MD

Blood (2013) 122 (21): 1344.

https://doi.org/10.1182/blood.V122.21.1344.1344

Published: 2013

Journal Articles

Identification Of Novel Markers Of Human AML Stem Cells Using High Resolution Proteomics and Transcriptomics

Simon Raffel, MD, Jenny Hansson, PhD, Lutz Christoph, MD, Daniel Klimmeck, PhD, Nina Cabezas-Wallscheid, PhD, Eike C. Buss, MD, Christian Thiede, MD, Anne Flörcken, MD, Sabrina Hanke, Marco Tinelli, MD, Oliver Bischel, MD, Christoph Rösli, PhD, Jörg Westermann, MD, Gerhard Ehninger, MD, Anthony D. Ho, MD, Jeroen Krijgsveld, PhD, Andreas Trumpp, PhD

Blood (2013) 122 (21): 4194.

https://doi.org/10.1182/blood.V122.21.4194.4194

Published: 2013

Journal Articles

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, MD, Joachim Beck, MD, Monika Brueggemann, Thomas Burmeister, MD, Eike C. Buss, MD, Norbert Frickhofen, MD, Andreas Huettmann, MD, Anke Morgner, MD, Albrecht Reichle, Ingo Schmidt-Wolf, MD, Stefan Schwartz, MD, Hubert Serve, Prof. Dr. med., Bernd M Spriewald, MD, Michael Starck, MD, Matthias Stelljes, MD, Andreas Viardot, MD, Knut Wendelin, MD, Dieter Hoelzer, MD

Blood (2012) 120 (21): 1493.

https://doi.org/10.1182/blood.V120.21.1493.1493

Published: 2012

Journal Articles

Treatment of Myelofibrosis Using I.V. Treosulfan and Autologous Peripheral Blood Progenitor Cell Transplantation Is Feasible and Results in Hematologic Responses – Long-Term Follow-up and Final Analysis of a One-Armed Clinical Study and of Individual Cases

Eike C. Buss, MD, Julian Topaly, MD, Hans H. Kreipe, MD, Stefan Fruehauf, MD, Anthony D. Ho, MD

Blood (2011) 118 (21): 4514.

https://doi.org/10.1182/blood.V118.21.4514.4514

Published: 2011

Journal Articles

Enhanced c-Met activity promotes G-CSF–induced mobilization of hematopoietic progenitor cells via ROS signaling

Blood (2011) 117 (2): 419–428.

https://doi.org/10.1182/blood-2009-06-230359

Published: 2011

Includes: Supplemental data

Journal Articles

In Vivo Mobilization of Leukemic Human Precursor-B-ALL Cells by the CXCR4-Antagonist AMD3100 Is Via Secretion of SDF-1 and Synergistically by Catecholamine Action.

Eike C. Buss, MD, Alexander Kalinkovich, MD, PhD, Amir Schajnovitz, MSc, Orit Kollet, PhD, Ayelet Dar, PhD, Melania Tesio, PhD, Stefan Fruehauf, MD, Marc Hotfilder, PhD, Anthony D. Ho, MD, Leonard D. Shultz, Tsvee Lapidot, PhD

Blood (2008) 112 (11): 1920.

https://doi.org/10.1182/blood.V112.11.1920.1920

Published: 2008

Journal Articles

Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with Myeloid Blast Crisis of Chronic Myeloid Leukemia.

Stefan Fruehauf, MD, Julian Topaly, MD, Eike C. Buss, MD, Tanja Lahaye, MD, Oliver G. Ottmann, MD, Thomas Fischer, MD, Bertold Emmerich, MD, Ulrike Haus, Rudiger Hehlmann, MD, Anthony D. Ho, MD, Andreas Hochhaus, MD

Blood (2005) 106 (11): 1105.

https://doi.org/10.1182/blood.V106.11.1105.1105

Published: 2005

Journal Articles

Quantitative Real Time PCR Analysis of MDR1 Transduced Rhesus Macaque Hematopoietic Stem Cells Shows No Indication for Proliferative Advantage after Long-Term Follow-Up.

Farastuk Bozorgmehr, Stephanie Laufs, PhD, Eike C. Buss, MD, Katalina Z. Nagy, Stephanie E. Sellers, PhD, W. Jens Zeller, MD, Cynthia E. Dunbar, MD, Stefan Fruehauf, MD

Blood (2005) 106 (11): 2198.

https://doi.org/10.1182/blood.V106.11.2198.2198

Published: 2005

Journal Articles

Myeloablative Conditioning of Patients with Myelofibrosis with Myeloid Metaplasia Using i.v. Treosulfan and Autologous Peripheral Blood Progenitor Cell Transplantation (PBPCT) with High Doses of CD34+ Cells Results in Hematologic Responses - 32 Months Follow-Up of Three Patients and Short-Term Results of a New Study.

Stefan Fruehauf, MD, Eike C. Buss, MD, Julian Toplay, MD, Hans H. Kreipe, MD, Anthony D. Ho, MD

Blood (2005) 106 (11): 5515.

https://doi.org/10.1182/blood.V106.11.5515.5515

Published: 2005

Journal Articles

New Aspects on the Safety of Multidrug-Resistance 1 Gene Transfers: No Indication for Clonal Dominance after Long-Term Follow-Up in a Primate Transplantation Model.

Farastuk Bozorgmehr, Eike C. Buss, Stephanie Laufs, K. Zsuzsanna Nagy, Stephanie Sellers, W. Jens Zeller, Cynthia E. Dunbar, Stefan Fruehauf

Blood (2004) 104 (11): 2108.

https://doi.org/10.1182/blood.V104.11.2108.2108

Published: 2004

Journal Articles

Myeloablative Conditioning in Myelofibrosis using i.v. Treosulfan and Autologous Peripheral Blood Progenitor Cell Transplantation with High Doses of CD34+ Cells Results in Hematologic Responses - Follow-Up of Three Patients.

Stefan Fruehauf, Eike C. Buss, Julian Topaly, Hans H. Kreipe, Anthony D. Ho

Blood (2004) 104 (11): 5220.

https://doi.org/10.1182/blood.V104.11.5220.5220

Published: 2004

Journal Articles

A Multicenter Phase I/II Trial of the Combination of Imatinib Mesylate with Mitoxantrone/Etoposide and Cytarabine in Patients with CML in Myeloid Blast Crisis: A Trend to a Longer Survival in Patients Receiving More Aggressive Treatment Schedules.

Stefan Fruehauf, MD, Julian Topaly, MD, Eike C. Buss, MD, Thomas Fischer, MD, Bertold Emmerich, MD, Harald Gschaidmeier, MD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD

Blood (2004) 104 (11): 2929.

https://doi.org/10.1182/blood.V104.11.2929.2929

Published: 2004

Journal Articles

Sufficient Mobilization of Peripheral Blood Stem Cells by Single Dose Application of Pegylated G-CSF in Patients with Multiple Myeloma, Interim Analysis of a Phase II Study.

Stefan Fruehauf, Seeger Timon, Eike C. Buss, Julian Topaly, Anthony D. Ho, Hartmut Goldschmidt

Blood (2004) 104 (11): 946.

https://doi.org/10.1182/blood.V104.11.946.946

Published: 2004

NARROW

Long-Term Follow-up of Patients with Mantle Cell Lymphoma Treated with Venetoclax Monotherapy

In-Depth Quantitative Multiplex Proteomics Reveal Subtype-Specific Differences Among Functionally Validated AML Stem Cell Populations

Favorable Outcome in a Large Cohort of Prospectively Treated Adult Patients with T-Lymphoblastic Lymphoma (T-LBL) Despite Slowly Evolving Complete Remission Assessed By Conventional Radiography

BLAST: A Confirmatory, Single-Arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE ® ) Antibody Construct, in Patients with Minimal Residual Disease B-Precursor Acute Lymphoblastic Leukemia (ALL)

Expression Of Aldehyde Dehydrogenase Reflected Diverse Stem Cell Properties In Acute Myeloid Leukemia

Identification Of Novel Markers Of Human AML Stem Cells Using High Resolution Proteomics and Transcriptomics

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Treatment of Myelofibrosis Using I.V. Treosulfan and Autologous Peripheral Blood Progenitor Cell Transplantation Is Feasible and Results in Hematologic Responses – Long-Term Follow-up and Final Analysis of a One-Armed Clinical Study and of Individual Cases

Enhanced c-Met activity promotes G-CSF–induced mobilization of hematopoietic progenitor cells via ROS signaling

In Vivo Mobilization of Leukemic Human Precursor-B-ALL Cells by the CXCR4-Antagonist AMD3100 Is Via Secretion of SDF-1 and Synergistically by Catecholamine Action.

Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with Myeloid Blast Crisis of Chronic Myeloid Leukemia.

Quantitative Real Time PCR Analysis of MDR1 Transduced Rhesus Macaque Hematopoietic Stem Cells Shows No Indication for Proliferative Advantage after Long-Term Follow-Up.

New Aspects on the Safety of Multidrug-Resistance 1 Gene Transfers: No Indication for Clonal Dominance after Long-Term Follow-Up in a Primate Transplantation Model.

Myeloablative Conditioning in Myelofibrosis using i.v. Treosulfan and Autologous Peripheral Blood Progenitor Cell Transplantation with High Doses of CD34+ Cells Results in Hematologic Responses - Follow-Up of Three Patients.

A Multicenter Phase I/II Trial of the Combination of Imatinib Mesylate with Mitoxantrone/Etoposide and Cytarabine in Patients with CML in Myeloid Blast Crisis: A Trend to a Longer Survival in Patients Receiving More Aggressive Treatment Schedules.

Sufficient Mobilization of Peripheral Blood Stem Cells by Single Dose Application of Pegylated G-CSF in Patients with Multiple Myeloma, Interim Analysis of a Phase II Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only